Shawnte struggled with her weight for years before she was prescribed Novo Nordisk’s diabetes drug Ozempic for weight loss in 2020, helping the former music industry professional from New York lose more than 50 pounds over two years.
Until late last year when Wegovy prescriptions began to rise, weight-loss coverage represented a marginal expense for employers because the available branded drugs were ineffective and little used, or readily substituted by cheaper generics, the healthcare consultants said.
that is being prescribed off-label but is not yet approved for weight loss, have changed that dynamic. Eli Lilly declined to comment on employers’ coverage policies. Novo Nordisk said Wegovy should be more broadly covered like medicines for other chronic diseases. "As long as there aren’t generic or cheaper versions , I think this is what we can continue to expect," said Duke University medical professor Dr. William Yancy.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A new pill may work as well as Ozempic and Wegovy shots to treat obesityNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes
Read more »
A daily pill may work as well as Ozempic, Wegovy shots to treat obesity: studyNew research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs may work as well as injections — even in hard-to-treat people with diabetes.
Read more »
A daily pill may work as well as Wegovy shots to treat obesity, study suggestsWhat if treating obesity could be as easy as popping an effective pill?
Read more »
Novo Nordisk says obesity pill leads to 15% weight loss; availability 'to be determined'Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose oral version of its drug semaglutide helped overweight or obese adults lose 15% of their body weight, which is in line with recent results for other experimental obesity pills.
Read more »
Pfizer to end development of experimental obesity pill due to elevated liver enzymesPfizer's two pills are part of the same class of obesity drugs as Novo Nordisk's blockbuster weight loss injections Ozempic and Wegovy.
Read more »
High-dose pill with the medication in the popular weight-loss injection Wegovy may be nearDrugmaker Novo Nordisk plans to ask the FDA to OK the weight-loss tablets later this year. Two new studies show significant success with them.
Read more »